Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35947817

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Dec 1
First author
Bauer S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Dec 1;40(34):3903-3906. doi: 10.1200/JCO.22.01406.
    note
    Source null
    related pmid
    36054848
    relationship
    Comment in

Authors and identifiers

  1. name
    Bauer S
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    Blay JY
    type
    Author
  4. name
    Gelderblom H
    type
    Author
  5. name
    George S
    type
    Author
  6. name
    Schöffski P
    type
    Author
  7. name
    von Mehren M
    type
    Author
  8. name
    Zalcberg JR
    type
    Author
  9. name
    Kang YK
    type
    Author
  10. name
    Razak AA
    type
    Author
  11. name
    Trent J
    type
    Author
  12. name
    Attia S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bauer S
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    Blay JY
    type
    Author
  4. name
    Gelderblom H
    type
    Author
  5. name
    George S
    type
    Author
  6. name
    Schöffski P
    type
    Author
  7. name
    von Mehren M
    type
    Author
  8. name
    Zalcberg JR
    type
    Author
  9. name
    Kang YK
    type
    Author
  10. name
    Razak AA
    type
    Author
  11. name
    Trent J
    type
    Author
  12. name
    Attia S
    type
    Author
bibliography ids
  1. nci-bib-30016b6ee53d3395f06daa8d
book metadata
content sha256
476eabef43b83bd5d7d7f834d95074d68b732885133925ae25fa2c5f1e15351c
document type
citation
dois
  1. 10.1200/JCO.22.00294
electronic publication date
display
2022 Aug 10
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35947817
immutable id
pubmed:35947817@476eabef43b83bd5d7d7f834d95074d68b732885133925ae25fa2c5f1e15351c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
34
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3918-3928
volume
40
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Dec 1;40(34):3903-3906. doi: 10.1200/JCO.22.01406.
    note
    Source null
    related pmid
    36054848
    relationship
    Comment in
outcomes validated
false
pmid
35947817
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
d1524ce9742c049692e809ee7d254262af343c0f9d3db9acf626f7cdc2cce9d5
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Dec 1
precision
day
year
2022
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35947817/
title
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.

Preserved source evidence · Not medical advice